Cargando…

Editorial: Metabolic Related Cardiomyopathy in Hyperglycemic Patients

Detalles Bibliográficos
Autores principales:	Capuano, Annalisa, Clementi, Emilio, Paolisso, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792897/ https://www.ncbi.nlm.nih.gov/pubmed/35097035 http://dx.doi.org/10.3389/fcvm.2021.826914

Ejemplares similares

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
por: Capuano, Annalisa, et al.
Publicado: (2022)

Covid-19 Kills More Men Than Women: An Overview of Possible Reasons
por: Capuano, Annalisa, et al.
Publicado: (2020)

miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2021)

Corrigendum: miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2022)

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

Editorial: Multimodality imaging in cardiomyopathy
por: Hays, Allison G., et al.
Publicado: (2023)

Editorial: Myocarditis and inflammatory cardiomyopathies: diagnosis, treatment and future directions
por: Gentile, Piero, et al.
Publicado: (2023)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Inflammation in Metabolic Cardiomyopathy
por: Wenzl, Florian A., et al.
Publicado: (2021)

Editorial: Understanding Molecular Mechanisms in Diabetic Cardiomyopathy (DCM)
por: Muthu, Sakthijothi, et al.
Publicado: (2022)

Editorial: New insights and future prospects of atrial cardiomyopathy
por: Li, Yan-Guang
Publicado: (2023)

Editorial: Molecular pathogenesis and novel treatments for inherited cardiomyopathies
por: Chou, Chun, et al.
Publicado: (2023)

Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy
por: Kain, Vasundhara, et al.
Publicado: (2017)

Advanced progress of the relationship between PCSK9 monoclonal antibodies and hyperglycemic adverse events
por: Zhang, Ruixing, et al.
Publicado: (2023)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

The multifaceted roles of ER and Golgi in metabolic cardiomyopathy
por: Raja, Rida, et al.
Publicado: (2022)

Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk
por: Lopes, Luis Rocha, et al.
Publicado: (2022)

Editorial: Clinical and Molecular Features of Infectious Cardiomyopathies: Implications for Prevention, Treatment and Management
por: Nunes, Maria do Carmo Pereira, et al.
Publicado: (2022)

Editorial: Metabolic hormones and inflammation
por: Gage, Matthew C., et al.
Publicado: (2022)

Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume II
por: Cardim, Nuno, et al.
Publicado: (2023)

Systematic analysis of myocardial immune progression in septic cardiomyopathy: Immune-related mechanisms in septic cardiomyopathy
por: Ma, Dunliang, et al.
Publicado: (2023)

Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
por: Fontanella, Rosaria Anna, et al.
Publicado: (2021)

Multifocal ectopic purkinje-related premature contractions and related cardiomyopathy
por: Calloe, Kirstine, et al.
Publicado: (2023)

Editorial: Mitochondria, metabolism and cardiovascular diseases
por: Koga, Jun-ichiro, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2023)

Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy
por: Zheng, Yue, et al.
Publicado: (2022)

COVID-19 and atrial fibrillation: Intercepting lines
por: Donniacuo, Maria, et al.
Publicado: (2023)

Editorial: Mitochondrial Metabolism in Ischemic Heart Disease
por: Yang, Lei, et al.
Publicado: (2022)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

Proteomic Analysis Suggests Altered Mitochondrial Metabolic Profile Associated With Diabetic Cardiomyopathy
por: Gomes, Karina P., et al.
Publicado: (2022)

Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism
por: Chauhan, Pankaj Kumar, et al.
Publicado: (2023)

Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy
por: Wang, Jianru, et al.
Publicado: (2022)

Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses
por: Zheng, Xifeng, et al.
Publicado: (2021)

Editorial: Inflammation, Metabolism and Epigenetics in Valvular Heart Disease
por: Jover, Eva, et al.
Publicado: (2022)

Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
por: Yan, Tong, et al.
Publicado: (2022)

Editorial: Cardiovascular imaging in the integrated assessment of metabolic health
por: Thomaides-Brears, Helena B., et al.
Publicado: (2023)

Mitochondrial Cardiomyopathies
por: El-Hattab, Ayman W., et al.
Publicado: (2016)

Electrocardiographic Screening of Arrhythmogenic Cardiomyopathy in Genotype-Positive and Phenotype-Negative Relatives
por: Lopez-Ayala, Jose Maria, et al.
Publicado: (2021)

Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ji27md0v22it1k4dj9mtdgn48d